AB Science annonce aujourd’hui les résultats de son étude de phase 3 évaluant le masitinib chez des patients atteints de mélanome non opérable ou métastatique de stade 3 ou stade 4
August 02, 2019 11:44 ET
|
AB Science
Paris, 2 août 2019, 17h30 AB Science annonce de nouveaux résultats cliniques en oncologie :L’activité du masitinib a été démontrée dans le mélanome métastatiqueprésentant une mutation du domaine...
AB Science today reports the analysis for its phase 3 trial evaluating masitinib in patients with non-resectable or metastatic stage 3 or stage 4 melanoma
August 02, 2019 11:44 ET
|
AB Science
Paris, August 2, 2019, 5.30pm AB Science announces new clinical results in oncology: Masitinib showed activity in metastatic melanoma bearingthe juxta-membrane mutation of c-Kit AB...
Ahead of Memorial Day, the American Academy of Dermatology Reminds Americans to Use Protection
May 23, 2019 11:30 ET
|
American Academy of Dermatology
ROSEMONT, Ill., May 23, 2019 (GLOBE NEWSWIRE) -- An estimated 9,500 people in the United States are diagnosed with skin cancer every day, yet many Americans will put themselves at greater risk for...
During Skin Cancer Awareness Month, Dermatologists Share 5 Common Sunscreen Mistakes — and How to Avoid Them; American Academy of Dermatology
May 14, 2019 14:30 ET
|
American Academy of Dermatology
ROSEMONT, Ill., May 14, 2019 (GLOBE NEWSWIRE) -- Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime. Yet according to dermatologists from...
Dermatologists Say Sunscreen is a Vital Tool in the Fight Against Skin Cancer, the Most Common Cancer in the U.S.; American Academy of Dermatology
May 07, 2019 11:30 ET
|
American Academy of Dermatology
ROSEMONT, Ill., May 07, 2019 (GLOBE NEWSWIRE) -- Recent news about sunscreen has many consumers confused about the best approach for sun protection, and some have questioned whether they should be...
“Do You Use Protection?” American Academy of Dermatology Study Finds Half of Americans Are Not Protecting Themselves Against Sun Damage
May 01, 2019 11:58 ET
|
American Academy of Dermatology
ROSEMONT, Ill., May 01, 2019 (GLOBE NEWSWIRE) -- Skin cancer is one of the most preventable types of cancer, yet new data shows Americans aren’t “practicing safe sun.” In a recent survey, the...
Pet Cancer Therapeutics Market to hit $359.4 Million by 2025: Global Market Insights, Inc.
March 15, 2019 03:04 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, March 15, 2019 (GLOBE NEWSWIRE) -- Australian pet cancer therapeutics market is forecast to grow at over 12.6% CAGR in given timeframe. High growth is due to growing...
Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma
February 13, 2019 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma Second CTA approval in 2019 – the first was for a NSCLC study Stevenage, UK 13 February...
Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma
February 13, 2019 03:00 ET
|
Achilles Therapeutics
Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma Second CTA approval in 2019 – the first was for a NSCLC study Stevenage, UK 13 February...
Dermatology Experts Present Latest Information at 2018 AAD Summer Meeting; American Academy of Dermatology
July 26, 2018 08:00 ET
|
American Academy of Dermatology
CHICAGO, July 26, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Summer Meeting will take place from July 26 to 29 at the Hyatt Regency Chicago. The meeting will feature the...